全球正子断层扫描（PET）市场规模、份额、趋势和成长分析报告（2026-2034年）

正子断层扫描（PET）市场预计将从 2025 年的 27.8 亿美元成长到 2034 年的 49.3 亿美元，2026 年至 2034 年的复合年增长率为 6.56%。

随着高解析度影像在肿瘤学、神经病学和心臟病学诊断中的重要性日益凸显，PET市场正在不断扩张。 PET系统可提供高解析度的功能性影像，用于疾病的早期检测、治疗进展监测和治疗方案製定。癌症、神经系统疾病和心血管疾病发生率的上升，以及混合影像技术（PET/CT、PET/MRI）的进步，正推动PET在全球医院、诊断中心和研究机构的广泛应用。

技术创新正在推动市场成长。数位PET检测器、飞行时间成像和人工智慧驱动的影像重建技术提高了解析度、诊断准确性和工作流程效率。放射性示踪技术的进步实现了靶向成像，从而降低了辐射暴露，提高了患者安全性。与基于云端的PACS和人工智慧分析的集成，有助于提供即时诊断支援、预测性诊断，并简化临床操作。

预计未来成长将主要得益于医疗保健投资的增加、癌症治疗基础设施的扩张以及人们对个人化医疗日益增长的兴趣。北美和欧洲凭藉其成熟的医疗保健体系引领PET技术的应用，而亚太地区则在诊断中心网路扩张和公共卫生政策的推动下实现了快速成长。设备製造商、研究机构和放射性药物公司之间的策略合作正在推动下一代PET解决方案的研发。 PET系统将继续在全球发挥关键作用，用于精准诊断和先进的治疗监测。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章 全球正子断层扫描（PET）市场：依产品类型划分

• 市场分析、洞察与预测
• 部分环形PET扫描仪
• 全环PET扫描仪

第五章 全球正子断层扫描（PET）市场：依检测器类型划分

• 市场分析、洞察与预测
• 镏镥 (LSO)
• 硅光电倍增器（SiPM）
• 镏钇钇 (LYSO)
• 数位光子计数器（DPC）
• 其他检测器类型

第六章 全球正子断层扫描（PET）市场：依最终用途划分

• 市场分析、洞察与预测
• 医院
• 诊断中心
• 门诊手术中心
• 其他最终用户

第七章 全球正子断层扫描（PET）市场：按地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第八章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第九章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Canon Medical Systems Corporation
  • CMR Naviscan Corporation
  • Fujifilm Holdings Corporation
  • GE Healthcare
  • Koninklijke Philips
  • Mediso
  • Minfound Medical Systems
  • Molecubes
  • Neusoft Corporation
  • Oncovision
  • Positron

The Positron Emission Tomography Market size is expected to reach USD 4.93 Billion in 2034 from USD 2.78 Billion (2025) growing at a CAGR of 6.56% during 2026-2034.

The PET market is expanding as precision imaging becomes critical for oncology, neurology, and cardiology diagnostics. PET systems provide high-resolution, functional imaging for early disease detection, therapy monitoring, and treatment planning. Rising prevalence of cancer, neurological disorders, and cardiovascular conditions, combined with advancements in hybrid imaging (PET/CT, PET/MRI), is driving global adoption across hospitals, diagnostic centers, and research institutions.

Technological innovation is shaping market growth. Digital PET detectors, time-of-flight imaging, and AI-driven image reconstruction enhance resolution, diagnostic accuracy, and workflow efficiency. Radiotracer advancements enable targeted imaging, reducing dosage and improving patient safety. Integration with cloud-based PACS and AI analytics supports real-time interpretation, predictive diagnostics, and streamlined clinical operations.

Future growth is expected from rising healthcare investments, expanding cancer care infrastructure, and growing focus on personalized medicine. North America and Europe lead adoption due to mature healthcare systems, while Asia-Pacific is witnessing rapid expansion through rising diagnostic center networks and public health initiatives. Strategic collaborations between device manufacturers, research institutions, and radiopharmaceutical companies are enabling next-generation PET solutions. PET systems are poised to remain essential in precision diagnostics and advanced therapeutic monitoring globally.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product Type

• Partial Ring PET Scanner
• Full Ring PET Scanner

By Detector Type

• Lutetium Oxyorthosilicate (LSO)
• Silicon Photomultiplier (SiPM)
• Lutetium Yttrium Orthosilicate (LYSO)
• Digital Photon Counters (DPC)
• Other Detector Types

By End Use

• Hospitals
• Diagnostic Centers
• Ambulatory Surgical Centers
• Other End Users

COMPANIES PROFILED

• Canon Medical Systems Corporation, CMR Naviscan Corporation, Fujifilm Holdings Corporation, GE Healthcare, Koninklijke Philips, Mediso, Minfound Medical Systems, Molecubes, Neusoft Corporation, Oncovision, Positron
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL POSITRON EMISSION TOMOGRAPHY MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product Type
• 4.2. Partial Ring PET Scanner Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Full Ring PET Scanner Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL POSITRON EMISSION TOMOGRAPHY MARKET: BY DETECTOR TYPE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Detector Type
• 5.2. Lutetium Oxyorthosilicate (LSO) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Silicon Photomultiplier (SiPM) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Lutetium Yttrium Orthosilicate (LYSO) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Digital Photon Counters (DPC) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Other Detector Types Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL POSITRON EMISSION TOMOGRAPHY MARKET: BY END USE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End Use
• 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Diagnostic Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Ambulatory Surgical Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Other End Users Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL POSITRON EMISSION TOMOGRAPHY MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Product Type
  • 7.2.2 By Detector Type
  • 7.2.3 By End Use
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Product Type
  • 7.3.2 By Detector Type
  • 7.3.3 By End Use
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Product Type
  • 7.4.2 By Detector Type
  • 7.4.3 By End Use
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Product Type
  • 7.5.2 By Detector Type
  • 7.5.3 By End Use
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Product Type
  • 7.6.2 By Detector Type
  • 7.6.3 By End Use
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL POSITRON EMISSION TOMOGRAPHY INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Canon Medical Systems Corporation
  • 9.2.2 CMR Naviscan Corporation
  • 9.2.3 Fujifilm Holdings Corporation
  • 9.2.4 GE Healthcare
  • 9.2.5 Koninklijke Philips
  • 9.2.6 Mediso
  • 9.2.7 Minfound Medical Systems
  • 9.2.8 Molecubes
  • 9.2.9 Neusoft Corporation
  • 9.2.10 Oncovision
  • 9.2.11 Positron